Abstract
Background Hypothermic machine perfusion (HMP) has become a standard method for preserving deceased donor kidneys, offering advantages over static cold storage. Perfusion parameters like renal vascular resistance (RR) have been explored as potential decision-making tools for kidney transplantability, but their clinical use remains unclear.
Aim We aimed to investigate the use of perfusion parameters in decision-making regarding the acceptance of pumped deceased donor kidneys among Organ Procurement Organizations (OPOs) in the USA and Canada.
Methods An anonymous, internet-based survey was sent to 69 OPOs in the USA and Canada, collecting data on the use of HMP, perfusion parameters, and thresholds for transplantability decisions. Descriptive statistics were used for analysis.
Results Of the 67 OPOs contacted, 15 (22%) responded, with 13 complete responses (87%). All OPOs used HMP, with 93% perfusing both donation after brain death and circulatory death kidneys. While 97% of OPOs used perfusion parameters in decision-making, none relied solely on these parameters. Two OPOs (15%) did not use them at all, while six OPOs (46%) considered them with other data or on a case-by-case basis. Only one OPO (9%) reported using specific thresholds for perfusion parameters, applying flow ≥100 mL/min, resistance <0.3 mmHg/mL/min, and pressure between 15–35 mmHg.
Conclusion HMP is widely used, but substantial variability exists in the use of perfusion parameters for transplant decisions. Most OPOs do not rely on these parameters alone and lack standardized thresholds, though specific thresholds are still used.
Competing Interest Statement
IJ received an unrestricted research grant from XVIVO Perfusion paid to her institution.
Clinical Protocols
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee REsearch of UZ/KU Leuven gave ethical approval for this work (reference number S69499).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
Data availability statement
All data produced in the present work are contained in the manuscript.
